Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, et al. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association. 2024. 31. 5. 526-533
Yosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, Wataru Fukuokaya, Yuhei Koike, Yuji Yata, Kazumasa Komura, Taizo Uchimoto, Takuya Tsujino, Kazuki Nishimura, et al. Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan. Journal of cancer research and clinical oncology. 2024. 150. 4. 182-182
Naoki Uchida, Fumihiko Urabe, Yushi Suhara, Yuma Goto, Kentaro Yoshihara, Ibuki Sadakane, Yuji Yata, Shiro Kurawaki, Keiichiro Miyajima, Mimu Ishikawa, et al. Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective study. Translational andrology and urology. 2024. 13. 3. 414-422
Fumihiko Urabe, Yuta Yamada, Shutaro Yamamoto, Shunsuke Tsuzuki, Shoji Kimura, Takahiro Ochiya, Takahiro Kimura. Extracellular vesicles and prostate cancer management: a narrative review. Translational andrology and urology. 2024. 13. 3. 442-453
Fumihiko Urabe, Takayuki Sumiyoshi, Kojiro Tashiro, Takayuki Goto, Takahiro Kimura, Takashi Kobayashi. Prostate cancer and liquid biopsies: Clinical applications and challenges. International journal of urology : official journal of the Japanese Urological Association. 2024